Shayne & Jacobs LLC’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$237K Hold
907
– – 0.07% 96
2026
Q2
$228K Buy
+907
New +$195K 0.07% 97
2026
Q1
– Sell
-907
Closed -$207K – 95
2025
Q4
$207K Hold
907
– – 0.06% 94
2025
Q3
$210K Buy
+907
New +$185K 0.07% 95
2015
Q3
– Sell
-3,163
Closed -$212K – 19
2015
Q2
$212K Sell
3,163
-305
-9% -$19.9K 0.18% 20
2015
Q1
$203K Hold
3,468
– – 0.16% 23
2014
Q4
$227K Sell
3,468
-293
-8% -$18.5K 0.17% 20
2014
Q3
$218K Hold
3,761
– – 0.17% 19
2014
Q2
$212K Sell
3,761
-555
-13% -$29.1K 0.17% 19
2014
Q1
$222K Hold
4,316
– – 0.18% 21
2013
Q4
$228K Buy
+4,316
New +$212K 0.19% 21

Other funds holding ABBV

Shayne & Jacobs LLC's ABBV Position: Q3 2026 in Review

Shayne & Jacobs LLC held its AbbVie (ABBV) position steady in Q3 2026 at 907 shares worth $237K. The position accounts for 0.07% of the portfolio, ranked #96.

Shayne & Jacobs LLC first reported a position in ABBV in Q4 2013 and has held it in 11 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Shayne & Jacobs LLC held 907 shares of AbbVie worth $237K as of Q3 2026.
  • Shayne & Jacobs LLC left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.07% of Shayne & Jacobs LLC's portfolio in Q3 2026, its #96 holding.
  • Shayne & Jacobs LLC first reported a position in AbbVie in Q4 2013 and has held it in 11 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Shayne & Jacobs LLC's 13F filing for Q3 2026, filed 21 Oct 2026.